NovoCure Ltd — Director's Dealing 2019

Jun 21, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2019-06-19

Reporting Person: Ambrogi Michael J. (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-06-19	Ordinary Shares	M	110868	$22.00	Acquired	296542	Direct
2019-06-19	Ordinary Shares	S	110868	$60.00	Disposed	185674	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-06-19	Options to Buy Ordinary Shares	$22.00	M	110868	Disposed	2025-10-01	Ordinary Shares (110868)	Direct

Footnotes

F1: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi.

F2: Fully vested as of the date hereof.